Skip to main content

Table 1 Characteristics of patients with psoriasis at baseline

From: Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis

 

Overall

Isolated HBcAb positive

HBcAb/HBsAb positive

HCV-Ab positive

N° of patients

224

23

36

15

Age, yrs (mean ± SD)

49 [±13.3]

66 [±10.6]

52 [±12.4]

62 [±11.8]

Gender (M/F) N°%

135/89 [60.2/39.7%]

10/13 [43.4/56.5%]

27/9 [75/25%]

11/4 [73.3/26.6%]

Pso

113 [50.5%]

10 [43.5%]

22 [61.1%]

9 [60%]

PsA

111 [49.5%]

13 [56.5%]

14 [38.9%]

6 [40%]

ALT, U/L (mean ± SD)

23 [±5.3]

27 [±2.3]

24 [±3.2]

25 [±2.1]

HBV-DNA positivity

0/224

0/23

0/36

0/15

HCV-RNA positivity

9/224

0/23

0/36

9/15

HBsAg positivity

0/224

0/23

0/36

0/15